Participates in Shareholder associations event in Malmoe.
A presentation of SensoDetect with an emphasis on the new approach and the change process which devised conducted by CEO Johan Olson at Aktiedagen on 27 September in Malmö. Shareholders Association (Aktiespararna) is hosting the event, which is one of the year's biggest stock events. Starting at 9.30 am a presentation is also available via webcast for those who can't attend (20 minutes presentation) and then followed by q & a on 10 minutes which also will be webcasted.
CEO Johan Olson will present the company, the new management team, his view of the market and the change process as well as the new strategy. Interested parties shall be given opportunity to ask questions during the presentation or in connection with the arrangement. Aktiespararnas Aktiedag in Malmö is one of the year's biggest events with 150-200 expected visitors to the seminars. In addition to that, about 15–20 000 take part in the event via the web.
Sensodetect BERA ® is a unique product that cost effectively can capture brainstem response of audio stimuli which can be used by Psychiatry as a complement to other observations at the screening of patients. For example, it is scientifically well highlighted that there is a clear link between ADHD and the part of the brain called the thalamus, this has been demonstrated, inter alia, with functional MRI. SensoDetects brainstem audiometer is a tool for detecting an abnormality in such as the thalamus. The user receives an objective metric which, like an elevated blood pressure, can be used as a supplement to support or reject a hypothesis in the diagnosis.
"- We are very pleased that we received the invitation to take part in this event and present SensoDetect, not least, to provide a picture of our new strategy and the process of change that has been made. We see this as a good opportunity to highlight our company and our view of the market going forward. I will use the opportunity to present the Board's and my image/vision on how we build a successful company.", says CEO Johan Olson
CEO, SensoDetect Aktiebolag (publ)
Phone: +46 46-15 12 73
SensoDetect highlights through patented equipment brain stem responses to audio stimuli in order to provide health care clear anomalies and patterns for use primarily within psychiatry. The goal is to increase efficiency in Psychiatry and thus the benefits for health care, society, patients and relatives.